克利妥珠单抗 T77191

Product Introduction
Bioactivity


英文名: Clivatuzumab

描述: Clivatuzumab为人源化抗粘液素单抗，可靶向大部分胰腺癌细胞表面高表达的MUC1表位，对多种肿瘤细胞均有较好的治疗效果。

体外活性: Clivatuzumab exhibits high specificity for pancreatic ductal adenocarcinoma (PDAC), showing minimal reactivity towards normal and benign non-tumorous pancreatic tissues. Although it demonstrates limited reactivity (approximately 10% of all samples) towards adenocarcinomas in certain other organs such as the stomach, colon, and lungs [1].

存储条件: store at low temperaturestore at -80°C

克利妥珠单抗 T77191信息由TargetMol中国为您提供，如您想了解更多关于克利妥珠单抗 T77191报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途